发明公开
EP1948172A1 DIARYL UREAS FOR TREATING DIABETIC NEUROPATHY 审中-公开
Diarylureas用于治疗糖尿病神经病变

  • 专利标题: DIARYL UREAS FOR TREATING DIABETIC NEUROPATHY
  • 专利标题(中): Diarylureas用于治疗糖尿病神经病变
  • 申请号: EP06828981.8
    申请日: 2006-11-09
  • 公开(公告)号: EP1948172A1
    公开(公告)日: 2008-07-30
  • 发明人: WEBER, OlafRIEDL, Bernd
  • 申请人: Bayer HealthCare AG
  • 申请人地址: 51368 Leverkusen DE
  • 专利权人: Bayer HealthCare AG
  • 当前专利权人: Bayer HealthCare AG
  • 当前专利权人地址: 51368 Leverkusen DE
  • 优先权: EP05024506 20051110; EP05027447 20051215
  • 国际公布: WO2007054302 20070518
  • 主分类号: A61K31/4375
  • IPC分类号: A61K31/4375 A61P25/00
DIARYL UREAS FOR TREATING DIABETIC NEUROPATHY
摘要:
The present invention relates to pharmaceutical compositions for treating diabetic neuropathy comprising at least a diaryl urea compound optionally combined with at least one additional therapeutic agent. Useful combinations include e.g. BAY 43-9006 as a diaryl urea compound.
信息查询
0/0